drugset / Trial / NCT03186131

Efficacy of Oral Ibandronate in Osteoporosis

NCT03186131

Phase 2 Unknown 100 enrolled Shinshu University
RandomizedParallel-groupSingle-blindTreatment

Summary

There has been no comparative data between oral ibandronate and oral ibandronate plus active vitamin D

Timeline

Start
2017-10-12
Primary completion
2022-12-08
Completion
2025-06-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibandronate Other / unclassified Oral
Comparator Vitamin D Other / unclassified Oral

Indications